Stock-based compensation
Flow – sum over the period · $M
Q4 2023
3.3a$M
derived
All values (14)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 64.0 | reported |
| Q1 2026 | 48.9 | reported |
| Q4 2025 | 41.4 | derived |
| Q3 2025 | 40.7 | reported |
| Q2 2025 | 35.5 | reported |
| Q1 2025 | 42.4 | reported |
| Q4 2024 | 48.2 | derived |
| Q3 2024 | 45.5 | reported |
| Q2 2024 | 43.1 | reported |
| Q1 2024 | 97.8 | reported |
| Q4 2023 | 3.3 | derived |
| Q3 2023 | 2.7 | reported |
| Q2 2023 | 2.7 | reported |
| Q1 2023 | 2.0 | reported |
| Q1 2016 – Q4 2022 | – | missing (28 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: sbc
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $3.0M (derived)
- Period
- Q4 2023, ended Dec 31, 2023 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 11M − 7M = $3.0M (FY value from 10-K 0001736297-25-000003; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 14, 2025 · 0001736297-25-000003
- Location
- us-gaap:ShareBasedCompensation
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $3.0M | Feb 14, 2025 | 10-K 0001736297-25-000003 | derived · confidence 1. · current |